Future implications of phase 2 chemotherapy trials in ninety-five patients with measurable advanced bladder cancer
Yagoda, A.
Cancer Research 37(8 Part 2): 2775-2780
1977
ISSN/ISBN: 0008-5472 PMID: 68814 Document Number: 111752
Document emailed within 1 workday
Related Documents
Sengeløv, L.; von der Maase, H. 2005: Chemotherapy as a supplement to radical treatment of patients with locally advanced bladder cancer Ugeskrift for Laeger 167(7): 749-751Gad-el-Mawla, N.; Ziegler, J.L.; Hamza, R.; Elserafi, M.; Khaled, H. 1984: Phase II chemotherapy trials of 5-FU, cyclophosphamide, ifosfamide, and vincristine in carcinoma of the bilharzial bladder Cancer Treatment Reports 68(2): 419-421
Recchia, F.; De Filippis, S.; Ginaldi, L.; Quaglino, D.; Gulino, A.; Frati, L.; Rea, S. 1997: Phase I-Ii study of dose intensified chemotherapy with filgrastim and thymopentin in patients with advanced cancer La Clinica Terapeutica 148(5-6): 201-207
Takahashi, K.; Mori, T.; Yamaguchi, T.; Matsumoto, H.; Miyamoto, H.; Arai, K.; Iwasaki, Y.; Katayanagi, S. 2004: The present and future of home care chemotherapy for patients with advanced and recurrent colorectal cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 31(Suppl 2): 154-156
Xiao, Y.-Y.; Zhan, P.; Yuan, D.-M.; Liu, H.-B.; Lv, T.-F.; Shi, Y.; Song, Y. 2013: Chemotherapy plus Vandetanib or chemotherapy alone in advanced non-small cell lung cancer: a meta-analysis of four randomised controlled trials Clinical Oncology 25(1): E7
Nichols, W.C.; Kvols, L.K.; Ingle, J.N.; Edmonson, J.H.; Ahmann, D.L.; Rubin, J.; O'Connell, M.J. 1978: Phase Ii study of triazinate and pyrazofurin in patients with advanced breast cancer previously exposed to cytotoxic chemotherapy Cancer Treatment Reports 62(5): 837-839
Israel, L.; Depierre, A.; Chahinian, P.; Le Bourgeois, J.P. 1971: Lessons from a series of 228 non measurable bronchial cancers and of 52 intrapulmonary measurable tumors under palliative chemotherapy Les Bronches 21(2): 220-223
Muthalib, A.; Darwis, I.; Prayogo, N.; Sutjipto 2000: Preliminary results of multicenter phase Ii trial of docetaxel (Taxotere) in combination with doxorubicin as first line chemotherapy in Indonesian patients with advanced or metastatic breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 27(Suppl 2): 498-504
Becouarn, Y.; Rougier, P. 1998: Clinical efficacy of oxaliplatin monotherapy: phase Ii trials in advanced colorectal cancer Seminars in Oncology 25(2 Suppl 5: 23-31
Horton, J.; Gelber, R.D.; Engstrom, P.; Falkson, G.; Moertel, C.; Brodovsky, H.; Douglass, H. 1981: Trials of single-agent and combination chemotherapy for advanced cancer of the pancreas Cancer Treatment Reports 65(1-2): 65-68
Jakse, G.; Frommhold, H. 1984: Combined radiation and chemotherapy for locally advanced bladder cancer Progress in Clinical and Biological Research 153: 365-372
Raghavan, D.; Pearson, B.; Watt, W.H.; Mameghan, H.; Langdon, P.; Eisinger, D.; Wines, R. 1991: Cytotoxic chemotherapy for advanced bladder cancer: cisplatin-containing regimens Seminars in Oncology 18(1 Suppl 3): 56-63
Lopez, M. 1999: The successes of cancer chemotherapy. the first cures of advanced-phase neoplasms La Clinica Terapeutica 150(5): 383-387
Droller, M. 2006: Bladder cancer: understanding the disease and future implications for assessment and therapy Revue Medicale Suisse 2(90): 2776-2778; 2781-2782, 2784
Scher, H.I. 1992: Systemic chemotherapy in regionally advanced bladder cancer. Theoretical considerations and results Urologic Clinics of North America 19(4): 747-759
Ozols, R.F.; Vermorken, J.B. 1997: Chemotherapy of advanced ovarian cancer: current status and future directions Seminars in Oncology 24(1 Suppl 2: S2
Pedrazzoli, P.; Zamagni, C.; Martoni, A.; Capotorto, A.M.; Da Prada, G.A.; Pavesi, L.; Preti, P.; Lelli, G.; Pannuti, F.; Robustelli della Cuna, G. 1994: Dose intensification of chemotherapy in advanced breast cancer: a feasibility phase II study Tumori 80(4): 273-275
Kunisaki, C.; Takahashi, M.; Nagahori, Y.; Makino, H.; Takagawa, R.; Sato, T.; Oshima, T.; Fujii, S.; Kosaka, T.; Ono, H.A.; Akiyama, H.; Shimada, H. 2008: Phase i study of biweekly docetaxel and S-1 combination chemotherapy for advanced gastric cancer Anticancer Research 28(4c): 2473-2478
Fujiwara, Y.; Fujita, J.; Kan, K.; Tsukahara, K.; Takiguchi, S.; Miyata, H.; Yasuda, T.; Doki, Y.; Monden, M. 2006: A phase i study of combination chemotherapy using TS-1 and weekly paclitaxel for advanced gastric cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 33(1): 45-48
Mommsen, S.; Jakobsen, A.; Sell, A. 1989: Quality of life in patients with advanced bladder cancer. a randomized study comparing cystectomy and irradiation--the Danish Bladder Cancer Study Group (DAVECA protocol 8201) Scandinavian Journal of Urology and Nephrology. Supplementum 125: 115-120